Document is current
Any future updates will be listed below
-
Authors
Tursi, Antonio https://orcid.org/0000-0001-5767-5541
Picchio, Marcello https://orcid.org/0000-0001-5070-8240
Elisei, Walter https://orcid.org/0000-0003-4951-0194
Brandimarte, Giovanni
Di Mario, Francesco
Danese, Silvio https://orcid.org/0000-0001-7341-1351
Papa, Alfredo https://orcid.org/0000-0002-4186-7298
-
Funding
Funding for this research was provided by:
Università Cattolica del Sacro Cuore
- License Information
-
More Information
Article History
Received: 30 July 2025
Accepted: 10 October 2025
First Online: 17 October 2025
Declarations
:
: The study was conducted in accordance with the World Medical Association Declaration of Helsinki (1975). It was approved by the Ethics Committee of the coordinating centre and all participating centres. The study was recorded at (NCT01534754).
: All study participants provided informed written consent before undergoing endoscopic investigation and participating in this study.
: Antonio Tursi served as speaker and/or consultant for AbbVie, Bayer, Fenix Pharma, Galápagos, Janssen, Nalkein, Omega Pharma, and Sila; Alfredo Papa served as a speaker for AlfaSigma and Janssen; Silvio Danese served as speaker, consultant, and/or advisory board member for AbbVie, Allergan, Alfa Wassermann, Biogen, Boehringer Ingelheim, Celgene, Celltrion, Ferring, Gilead, Hospira, Johnson & Johnson, Merck, MSD, Mundipharma, Pfizer Inc., Sandoz, Takeda, Tigenix, UCB Pharma, and Vifor. The remaining authors declare no competing interests.
